Dr. John Trachtenberg received his B.Sc., M.D. and C.M. from McGill University in Montreal. He completed his urologic residency at McGill University and succeeded to a fellowship in prostatic disease at Johns Hopkins University. Dr. Trachtenberg is currently Professor of Surgery and Medical Imaging at the University of Toronto. He holds the prestigious Fleck Tanenbaum Chair in Prostatic Diseases at the University of Toronto and University Health Network. He is the Director of the Prostate Centre at the Princess Margaret Hospital of the University Health Network. He acts as a consultant to the Urology Department at numerous hospitals. Dr. Trachtenberg has published over 225 peer reviewed scientific papers and several books, and sits on many hospital, university and scientific committees throughout North America and Europe. His accomplishments have earned him 18 awards, including Man of the Year in Sciences and Medicine from the Canadian Prostate Cancer Research Fund. He has developed novel, minimally invasive surgical techniques for the treatment of prostate cancer and was instrumental in the development of the prostate-specific Clinical Research Program at Princess Margaret Hospital.
Dr. Trachtenberg's major interests include the investigation of novel treatments for localized and advanced prostate cancer, developing minimally invasive image guided treatments for prostate cancer and the measurement and preservation of the quality of life of men with prostate cancer.
Limitations in predicting organ-confined prostate cancer in patients with Gleason pattern 4 on biopsy: Implications for active surveillance.
J Urol. 2016 Jul 22;
Influence of Metabolic Syndrome on Prostate Cancer Stage, Grade and Overall Recurrence Risk in Men Undergoing Radical Prostatectomy.
Urology. 2016 Mar 22;
Curr Oncol. 2015 Dec;22(6):374-84
A pilot randomized trial of conventional versus advanced pelvic floor exercises to treat urinary incontinence after radical prostatectomy: a study protocol.
BMC Urol. 2015;15(1):94
Can Urol Assoc J. 2015 May-Jun;9(5-6):179-87
Real-Time MRI-Guided Focused Ultrasound for Focal Therapy of Locally Confined Low-Risk Prostate Cancer: Feasibility and Preliminary Outcomes.
AJR Am J Roentgenol. 2015 Aug;205(2):W177-84
Indian J Urol. 2015 Jul-Sep;31(3):209-16
Curr Opin Urol. 2015 Feb 18;
Evaluation of models predicting insignificant prostate cancer to select men for active surveillance of prostate cancer.
Prostate Cancer Prostatic Dis. 2015 Feb 10;
Med Image Anal. 2015 Jan 8;
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Director, The Prostate Centre, University Health Network
Professor of Surgery and Medical Imaging, University of Toronto